In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma

• Main Authors: Marc-Eric Halatsch (Author), Annika Dwucet (Author), Carl Julius Schmidt (Author), Julius Mühlnickel (Author), Tim Heiland (Author), Katharina Zeiler (Author), Markus D. Siegelin (Author), Richard Eric Kast (Author), Georg Karpel-Massler (Author)
• Format: Book
• Published: MDPI AG, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Glioblastoma represents the most common primary brain tumor in adults. Despite technological advances, patients with this disease typically die within 1-2 years after diagnosis. In the search for novel therapeutics, drug repurposing has emerged as an alternative to traditional drug devel...